| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +40.00% | +6.63% | +0.12% | +6.51% | -3.25% | — |
| 14d | 5 | +80.00% | +10.70% | +0.19% | +10.51% | +1.89% | — |
| 30d | 5 | +40.00% | +27.45% | +1.27% | +26.18% | +24.35% | — |
| 60d | 5 | +20.00% | +16.41% | +3.14% | +13.28% | +9.12% | — |
| 90d | 5 | +20.00% | +22.57% | +1.30% | +21.27% | +32.86% | — |
| 180d | 5 | +40.00% | +8.68% | +9.11% | -0.43% | -25.05% | — |
| 1y | 5(1 pending) | +25.00% | +32.41% | +14.57% | +17.84% | -20.18% | — |
| 2y | 5(2 pending) | +33.33% | +24.96% | +38.37% | -13.42% | -48.20% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 29,888 | — | — | 29,888 | Jun 26, 2026 | Jun 29, 2026 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 35,500 | — | — | 35,500 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 214,000 | — | — | 214,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 19,532 | — | — | 19,532 | Jan 1, 2026 | Jan 5, 2026 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 10,720 | $9.06 | $97.1K | 68,149 | Dec 16, 2025 | Dec 17, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASE Chief Medical Officer | 29,333 | — | — | 78,869 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 8,000 | — | — | 0 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 10,000 | — | — | 10,000 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 11,333 | — | — | 22,667 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Jun 24, 2025 | Jun 26, 2025 ↗ | View → |
| ERAS ERASCA, INC. | SALEGRANT Gift | 6,200 | — | — | 166,666 | May 23, 2025 | Jun 3, 2025 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Gift | 6,200 | — | — | 6,200 | May 23, 2025 | Jun 3, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 34,000 | — | — | 34,000 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 202,500 | — | — | 202,500 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 8,850 | $8.28 | $73.3K | 46,765 | Dec 16, 2024 | Dec 17, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 6,042 | — | — | 0 | Dec 15, 2024 | Dec 17, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASE Chief Medical Officer | 24,042 | — | — | 55,615 | Dec 15, 2024 | Dec 17, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 8,000 | — | — | 8,000 | Dec 15, 2024 | Dec 17, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 10,000 | — | — | 20,000 | Dec 15, 2024 | Dec 17, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Jun 20, 2024 | Jun 21, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jan 2, 2024 | Jan 3, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 180,000 | — | — | 180,000 | Jan 2, 2024 | Jan 3, 2024 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 32,867 | — | — | 32,867 | Jan 1, 2024 | Jan 3, 2024 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 8,000 | — | — | 16,000 | Dec 15, 2023 | Dec 19, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 6,042 | — | — | 6,042 | Dec 15, 2023 | Dec 19, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASE Chief Medical Officer | 14,042 | — | — | 29,091 | Dec 15, 2023 | Dec 19, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 5,282 | $8.59 | $45.4K | 23,809 | Dec 15, 2023 | Dec 19, 2023 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Jun 22, 2023 | Jun 26, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 24,000 | — | — | 24,000 | Feb 1, 2023 | Feb 2, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 145,000 | — | — | 145,000 | Feb 1, 2023 | Feb 2, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASE Chief Medical Officer | 6,041 | — | — | 9,512 | Dec 15, 2022 | Dec 16, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 6,041 | — | — | 12,084 | Dec 15, 2022 | Dec 16, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 2,089 | $3.25 | $6.8K | 7,423 | Dec 15, 2022 | Dec 16, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 2,227 | $3.07 | $6.8K | 7,285 | Dec 15, 2022 | Feb 17, 2023 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 108,750 | — | — | 0 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 90,000 | — | — | 0 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 108,750 | — | — | 108,750 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | SALE Chief Medical Officer | 147,500 | — | — | 0 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 147,500 | — | — | 147,500 | Jul 20, 2022 | Jul 21, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 22, 2022 | Jun 24, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 18,125 | — | — | 18,125 | Feb 1, 2022 | Feb 2, 2022 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 108,750 | — | — | 108,750 | Feb 1, 2022 | Feb 2, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 6,200 | $16.00 | $99.2K | 172,866 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Feb 1, 2021 | Feb 2, 2021 ↗ | View → |
| ORIC ORIC PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 147,500 | — | — | 147,500 | Apr 23, 2020 | Apr 27, 2020 ↗ | View → |